Movers and shakers: Cell cytoskeleton in cancer metastasis

British Journal of Pharmacology

Volumn 171, Issue 24, 2014, Pages 5507-5523

  Fife, C M ^a,b   McCarroll, J A ^a,b   Kavallaris, M ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN; COFILIN; MYOSIN ADENOSINE TRIPHOSPHATASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TROPOMYOSIN;

CANCER CELL; CANCER CHEMOTHERAPY; CANCER MORTALITY; CELL MIGRATION; CELL MOTILITY; CELL MOTION; CYTOSKELETON; DOWNSTREAM PROCESSING; EXTRACELLULAR MATRIX; FOCAL ADHESION; HUMAN; HUMAN CELL; INTERMEDIATE FILAMENT; METASTASIS; MICROFILAMENT; MICROTUBULE; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; TUMOR INVASION; ACTIN FILAMENT; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ACTIN CYTOSKELETON; CELL MOVEMENT; CYTOSKELETON; HUMANS; INTERMEDIATE FILAMENTS; MICROTUBULES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 84918831129     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12704     Document Type: Review

References (155)

1. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, Peters JA, Harmar AJ, and CGTP Collaborators (2013a). The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol 170: 1459-1581.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, Peters JA, Harmar AJ, and CGTP Collaborators (2013b). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol 170: 1797-1867.
3. Akhshi TK, Wernike D, Piekny A, (2014). Microtubules and actin crosstalk in cell migration and division. Cytoskeleton (Hoboken) 71: 1-23.
4. Amin E, Dubey BN, Zhang SC, Gremer L, Dvorsky R, Moll JM, et al. (2013). Rho-kinase: regulation, (dys)function, and inhibition. Biol Chem 394: 1399-1410.
5. Ara T, DeClerck YA, (2006). Mechanisms of invasion and metastasis in human neuroblastoma. Cancer Metastasis Rev 25: 645-657.
6. Bach CT, Creed S, Zhong J, Mahmassani M, Schevzov G, Stehn J, et al. (2009). Tropomyosin isoform expression regulates the transition of adhesions to determine cell speed and direction. Mol Cell Biol 29: 1506-1514.
7. Bach CT, Schevzov G, Bryce NS, Gunning PW, O'Neill GM, (2010). Tropomyosin isoform modulation of focal adhesion structure and cell migration. Cell Adh Migr 4: 226-234.
8. Bagheri-Yarmand R, Mazumdar A, Sahin AA, Kumar R, (2006). LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system. Int J Cancer 118: 2703-2710.
9. Baldassarre G, Belletti B, Nicoloso MS, Schiappacassi M, Vecchione A, Spessotto P, et al. (2005). p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell 7: 51-63.
10. Belletti B, Baldassarre G, (2011). Stathmin: a protein with many tasks. New biomarker and potential target in cancer. Expert Opin Ther Targets 15: 1249-1266.
11. Bernard O, (2007). Lim kinases, regulators of actin dynamics. Int J Biochem Cell Biol 39: 1071-1076.
12. Bharadwaj S, Thanawala R, Bon G, Falcioni R, Prasad GL, (2005). Resensitization of breast cancer cells to anoikis by tropomyosin-1: role of Rho kinase-dependent cytoskeleton and adhesion. Oncogene 24: 8291-8303.
13. Broussard JA, Webb DJ, Kaverina I, (2008). Asymmetric focal adhesion disassembly in motile cells. Curr Opin Cell Biol 20: 85-90.
14. Byrne FA, Yang Y, Phillips AA, Hansford LM, Fletcher JI, Ormandy CJ, et al. (2014). RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse model. Oncogene 33: 882-890.
15. Cai JH, Zhao R, Zhu JW, Jin XL, Wan FJ, Liu K, et al. (2010). Expression of cortactin correlates with a poor prognosis in patients with stages II-III colorectal adenocarcinoma. J Gastrointest Surg 14: 1248-1257.
16. Capetanaki Y, Bloch RJ, Kouloumenta A, Mavroidis M, Psarras S, (2007). Muscle intermediate filaments and their links to membranes and membranous organelles. Exp Cell Res 313: 2063-2076.
17. Chang L, Goldman RD, (2004). Intermediate filaments mediate cytoskeletal crosstalk. Nat Rev Mol Cell Biol 5: 601-613.
18. Charras G, Paluch E, (2008). Blebs lead the way: how to migrate without lamellipodia. Nat Rev Mol Cell Biol 9: 730-736.
19. Chaudary N, Hill RP, (2007). Hypoxia and metastasis. Clin Cancer Res 13: 1947-1949.
20. Chuma M, Sakamoto M, Yasuda J, Fujii G, Nakanishi K, Tsuchiya A, et al. (2004). Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. J Hepatol 41: 629-636.
21. Cordes N, van Beuningen D, (2003). Cell adhesion to the extracellular matrix protein fibronectin modulates radiation-dependent G2 phase arrest involving integrin-linked kinase (ILK) and glycogen synthase kinase-3beta (GSK-3beta) in vitro. Br J Cancer 88: 1470-1479.
22. Cristofanilli M, (2012). Advancements in the treatment of metastatic breast cancer (MBC): the role of ixabepilone. J Oncol 2012: 703858.
23. Di Modugno F, Mottolese M, Di Benedetto A, Conidi A, Novelli F, Perracchio L, et al. (2006). The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2-positive/hormonal receptor-negative tumors. Clin Cancer Res 12: 1470-1478.
24. Di Vizio D, Kim J, Hager MH, Morello M, Yang W, Lafargue CJ, et al. (2009). Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. Cancer Res 69: 5601-5609.
25. Dowling P, Meleady P, Dowd A, Henry M, Glynn S, Clynes M, (2007). Proteomic analysis of isolated membrane fractions from superinvasive cancer cells. Biochim Biophys Acta 1774: 93-101.
26. Dumontet C, Jordan MA, (2010). Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat Rev Drug Discov 9: 790-803.
27. Edwards DC, Sanders LC, Bokoch GM, Gill GN, (1999). Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat Cell Biol 1: 253-259.
28. Eitaki M, Yamamori T, Meike S, Yasui H, Inanami O, (2012). Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells. BMC Cancer 12: 469.
29. Etienne-Manneville S, Hall A, (2001). Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCzeta. Cell 106: 489-498.
30. Fackler OT, Grosse R, (2008). Cell motility through plasma membrane blebbing. J Cell Biol 181: 879-884.
31. Finger EC, Giaccia AJ, (2010). Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer Metastasis Rev 29: 285-293.
32. Fortin Ensign SP, Mathews IT, Symons MH, Berens ME, Tran NL, (2013). Implications of Rho GTPase signaling in glioma cell invasion and tumor progression. Front Oncol 3: 241.
33. Gan PP, Kavallaris M, (2008). Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity. Cancer Res 68: 9817-9824.
34. Gan PP, Pasquier E, Kavallaris M, (2007). Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer. Cancer Res 67: 9356-9363.
35. Geiger TR, Peeper DS, (2009). Metastasis mechanisms. Biochim Biophys Acta 1796: 293-308.
36. Gibcus JH, Mastik MF, Menkema L, de Bock GH, Kluin PM, Schuuring E, et al. (2008). Cortactin expression predicts poor survival in laryngeal carcinoma. Br J Cancer 98: 950-955.
37. Green KJ, Jones JC, (1996). Desmosomes and hemidesmosomes: structure and function of molecular components. FASEB J 10: 871-881.
38. Gunnersen JM, Spirkoska V, Smith PE, Danks RA, Tan SS, (2000). Growth and migration markers of rat C6 glioma cells identified by serial analysis of gene expression. Glia 32: 146-154.
39. Gunning P, O'Neill G, Hardeman E, (2008). Tropomyosin-based regulation of the actin cytoskeleton in time and space. Physiol Rev 88: 1-35.
40. Gupton SL, Waterman-Storer CM, (2006). Spatiotemporal feedback between actomyosin and focal-adhesion systems optimizes rapid cell migration. Cell 125: 1361-1374.
41. Hailat N, Strahler J, Melhem R, Zhu XX, Brodeur G, Seeger RC, et al. (1990). N-myc gene amplification in neuroblastoma is associated with altered phosphorylation of a proliferation related polypeptide (Op18). Oncogene 5: 1615-1618.
42. Hall A, (2012). Rho family GTPases. Biochem Soc Trans 40: 1378-1382.
43. Hanahan D, Weinberg RA, (2011). Hallmarks of cancer: the next generation. Cell 144: 646-674.
44. Hao X, Sun B, Hu L, Lahdesmaki H, Dunmire V, Feng Y, et al. (2004). Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer 100: 1110-1122.
45. Horita Y, Ohashi K, Mukai M, Inoue M, Mizuno K, (2008). Suppression of the invasive capacity of rat ascites hepatoma cells by knockdown of Slingshot or LIM kinase. J Biol Chem 283: 6013-6021.
46. Horiuchi A, Imai T, Wang C, Ohira S, Feng Y, Nikaido T, et al. (2003). Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma. Lab Invest 83: 861-870.
47. Hsu KF, Lin CK, Yu CP, Tzao C, Lee SC, Lee YY, et al. (2009). Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma. Dis Esophagus 22: 402-408.
48. Huang S, Ingber DE, (1999). The structural and mechanical complexity of cell-growth control. Nat Cell Biol 1: E131-E138.
49. Ishiwata T, Matsuda Y, Naito Z, (2011). Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis. World J Gastroenterol 17: 409-418.
50. Iwaya K, Norio K, Mukai K, (2007a). Coexpression of Arp2 and WAVE2 predicts poor outcome in invasive breast carcinoma. Mod Pathol 20: 339-343.
51. Iwaya K, Oikawa K, Semba S, Tsuchiya B, Mukai Y, Otsubo T, et al. (2007b). Correlation between liver metastasis of the colocalization of actin-related protein 2 and 3 complex and WAVE2 in colorectal carcinoma. Cancer Sci 98: 992-999.
52. Jaffe AB, Hall A, (2005). Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 21: 247-269.
53. Jiang H, Yu XM, Zhou XM, Wang XH, Su D, (2013). Correlation between microtubule-associated gene expression and chemosensitivity of patients with stage II non-small cell lung cancer. Exp Ther Med 5: 1506-1510.
54. Jordan MA, Wilson L, (2004). Microtubules as a target for anticancer drugs. Nat Rev Cancer 4: 253-265.
55. Kamai T, Tsujii T, Arai K, Takagi K, Asami H, Ito Y, et al. (2003). Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 9: 2632-2641.
56. Kamai T, Yamanishi T, Shirataki H, Takagi K, Asami H, Ito Y, et al. (2004). Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin Cancer Res 10: 4799-4805.
57. Karlsson R, Pedersen ED, Wang Z, Brakebusch C, (2009). Rho GTPase function in tumorigenesis. Biochim Biophys Acta 1796: 91-98.
58. Katsumi A, Orr AW, Tzima E, Schwartz MA, (2004). Integrins in mechanotransduction. J Biol Chem 279: 12001-12004.
59. Kavallaris M, (2010). Microtubules and resistance to tubulin-binding agents. Nat Rev Cancer 10: 194-204.
60. Kaverina I, Straube A, (2011). Regulation of cell migration by dynamic microtubules. Semin Cell Dev Biol 22: 968-974.
61. Keshamouni VG, Michailidis G, Grasso CS, Anthwal S, Strahler JR, Walker A, et al. (2006). Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J Proteome Res 5: 1143-1154.
62. Khanna C, Khan J, Nguyen P, Prehn J, Caylor J, Yeung C, et al. (2001). Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res 61: 3750-3759.
63. Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A, et al. (2004). The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10: 182-186.
64. Kim H, Nakamura F, Lee W, Hong C, Perez-Sala D, McCulloch CA, (2010a). Regulation of cell adhesion to collagen via beta1 integrins is dependent on interactions of filamin A with vimentin and protein kinase C epsilon. Exp Cell Res 316: 1829-1844.
65. Kim H, Nakamura F, Lee W, Shifrin Y, Arora P, McCulloch CA, (2010b). Filamin A is required for vimentin-mediated cell adhesion and spreading. Am J Physiol Cell Physiol 298: C221-C236.
66. Kleer CG, van Golen KL, Zhang Y, Wu ZF, Rubin MA, Merajver SD, (2002). Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am J Pathol 160: 579-584.
67. Komlodi-Pasztor E, Sackett D, Wilkerson J, Fojo T, (2011). Mitosis is not a key target of microtubule agents in patient tumors. Nat Rev Clin Oncol 8: 244-250.
68. Kuo MF, Wang HS, Kuo QT, Shun CT, Hsu HC, Yang SH, et al. (2009). High expression of stathmin protein predicts a fulminant course in medulloblastoma. J Neurosurg Pediatr 4: 74-80.
69. Lamouille S, Xu J, Derynck R, (2014). Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15: 178-196.
70. Langley RR, Fidler IJ, (2011). The seed and soil hypothesis revisited-the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer 128: 2527-2535.
71. Lee YY, Yu CP, Lin CK, Nieh S, Hsu KF, Chiang H, et al. (2009). Expression of survivin and cortactin in colorectal adenocarcinoma: association with clinicopathological parameters. Dis Markers 26: 9-18.
72. Lees JG, Bach CT, Bradbury P, Paul A, Gunning PW, O'Neill GM, (2011). The actin-associating protein Tm5NM1 blocks mesenchymal motility without transition to amoeboid motility. Oncogene 30: 1241-1251.
73. Li X, Zheng H, Hara T, Takahashi H, Masuda S, Wang Z, et al. (2008). Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas. Int J Oncol 33: 69-79.
74. Lim Y, Lim ST, Tomar A, Gardel M, Bernard-Trifilo JA, Chen XL, et al. (2008). PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility. J Cell Biol 180: 187-203.
75. Luduena RF, (2013). A hypothesis on the origin and evolution of tubulin. Int Rev Cell Mol Biol 302: 41-185.
76. Luo ML, Shen XM, Zhang Y, Wei F, Xu X, Cai Y, et al. (2006). Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. Cancer Res 66: 11690-11699.
77. Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A, et al. (1999). Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 285: 895-898.
78. Martin TA, Pereira G, Watkins G, Mansel RE, Jiang WG, (2008). N-WASP is a putative tumour suppressor in breast cancer cells, in vitro and in vivo, and is associated with clinical outcome in patients with breast cancer. Clin Exp Metastasis 25: 97-108.
79. Martins GG, Kolega J, (2012). A role for microtubules in endothelial cell protrusion in three-dimensional matrices. Biol Cell 104: 271-286.
80. Martoglio AM, Tom BD, Starkey M, Corps AN, Charnock-Jones DS, Smith SK, (2000). Changes in tumorigenesis- and angiogenesis-related gene transcript abundance profiles in ovarian cancer detected by tailored high density cDNA arrays. Mol Med 6: 750-765.
81. McBride A, Butler SK, (2012). Eribulin mesylate: a novel halichondrin B analogue for the treatment of metastatic breast cancer. Am J Health Syst Pharm 69: 745-755.
82. McCarroll JA, Gan PP, Liu M, Kavallaris M, (2010). betaIII-tubulin is a multifunctional protein involved in drug sensitivity and tumorigenesis in non-small cell lung cancer. Cancer Res 70: 4995-5003.
83. Mierke CT, Rosel D, Fabry B, Brabek J, (2008). Contractile forces in tumor cell migration. Eur J Cell Biol 87: 669-676.
84. Molina A, Velot L, Ghouinem L, Abdelkarim M, Bouchet BP, Luissint AC, et al. (2013). ATIP3, a novel prognostic marker of breast cancer patient survival, limits cancer cell migration and slows metastatic progression by regulating microtubule dynamics. Cancer Res 73: 2905-2915.
85. Mouneimne G, Soon L, DesMarais V, Sidani M, Song X, Yip SC, et al. (2004). Phospholipase C and cofilin are required for carcinoma cell directionality in response to EGF stimulation. J Cell Biol 166: 697-708.
86. Mouneimne G, DesMarais V, Sidani M, Scemes E, Wang W, Song X, et al. (2006). Spatial and temporal control of cofilin activity is required for directional sensing during chemotaxis. Curr Biol 16: 2193-2205.
87. Niethammer P, Bastiaens P, Karsenti E, (2004). Stathmin-tubulin interaction gradients in motile and mitotic cells. Science 303: 1862-1866.
88. Nobes CD, Hall A, (1995). Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81: 53-62.
89. Palazzo AF, Gundersen GG, (2002). Microtubule-actin cross-talk at focal adhesions. Sci STKE 2002: pe31.
90. Pan Y, Jing R, Pitre A, Williams BJ, Skalli O, (2008). Intermediate filament protein synemin contributes to the migratory properties of astrocytoma cells by influencing the dynamics of the actin cytoskeleton. FASEB J 22: 3196-3206.
91. Pasquier E, Kavallaris M, Andre N, (2010). Metronomic chemotherapy: new rationale for new directions. Nat Rev Clin Oncol 7: 455-465.
92. Patel RA, Liu Y, Wang B, Li R, Sebti SM, (2014). Identification of novel ROCK inhibitors with anti-migratory and anti-invasive activities. Oncogene 33: 550-555.
93. Peacock JG, Miller AL, Bradley WD, Rodriguez OC, Webb DJ, Koleske AJ, (2007). The Abl-related gene tyrosine kinase acts through p190RhoGAP to inhibit actomyosin contractility and regulate focal adhesion dynamics upon adhesion to fibronectin. Mol Biol Cell 18: 3860-3872.
94. Pellegrin S, Mellor H, (2007). Actin stress fibres. J Cell Sci 120 (Pt 20): 3491-3499.
95. Perry SV, (2001). Vertebrate tropomyosin: distribution, properties and function. J Muscle Res Cell Motil 22: 5-49.
96. Pollard TD, Borisy GG, (2003). Cellular motility driven by assembly and disassembly of actin filaments. Cell 112: 453-465.
97. Po'uha ST, Shum MS, Goebel A, Bernard O, Kavallaris M, (2010). LIM-kinase 2, a regulator of actin dynamics, is involved in mitotic spindle integrity and sensitivity to microtubule-destabilizing drugs. Oncogene 29: 597-607.
98. Po'uha ST, Honore S, Braguer D, Kavallaris M, (2013). Partial depletion of gamma-actin suppresses microtubule dynamics. Cytoskeleton (Hoboken) 70: 148-160.
99. Prudent R, Vassal-Stermann E, Nguyen CH, Pillet C, Martinez A, Prunier C, et al. (2012). Pharmacological inhibition of LIM kinase stabilizes microtubules and inhibits neoplastic growth. Cancer Res 72: 4429-4439.
100. Rath N, Olson MF, (2012). Rho-associated kinases in tumorigenesis: re-considering ROCK inhibition for cancer therapy. EMBO Rep 13: 900-908.
101. Rico B, Beggs HE, Schahin-Reed D, Kimes N, Schmidt A, Reichardt LF, (2004). Control of axonal branching and synapse formation by focal adhesion kinase. Nat Neurosci 7: 1059-1069.
102. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, et al. (2003). Cell migration: integrating signals from front to back. Science 302: 1704-1709.
103. Rodrigo JP, Garcia-Carracedo D, Garcia LA, Menendez S, Allonca E, Gonzalez MV, et al. (2009). Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas. J Pathol 217: 516-523.
104. Rodrigues-Ferreira S, Di Tommaso A, Dimitrov A, Cazaubon S, Gruel N, Colasson H, et al. (2009). 8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis. PLoS ONE 4: e7239.
105. Ross-Macdonald P, de Silva H, Guo Q, Xiao H, Hung CY, Penhallow B, et al. (2008). Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors. Mol Cancer Ther 7: 3490-3498.
106. Rossman KL, Der CJ, Sondek J, (2005). GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 6: 167-180.
107. Rotty JD, Wu C, Bear JE, (2013). New insights into the regulation and cellular functions of the ARP2/3 complex. Nat Rev Mol Cell Biol 14: 7-12.
108. Sahai E, Marshall CJ, (2002). RHO-GTPases and cancer. Nat Rev Cancer 2: 133-142.
109. Sahai E, Marshall CJ, (2003). Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 5: 711-719.
110. Satelli A, Li S, (2011). Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 68: 3033-3046.
111. Schlaepfer DD, Mitra SK, (2004). Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev 14: 92-101.
112. Schmalbach CE, Chepeha DB, Giordano TJ, Rubin MA, Teknos TN, Bradford CR, et al. (2004). Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130: 295-302.
113. Schroeder A, Heller DA, Winslow MM, Dahlman JE, Pratt GW, Langer R, et al. (2012). Treating metastatic cancer with nanotechnology. Nat Rev Cancer 12: 39-50.
114. Scott RW, Hooper S, Crighton D, Li A, Konig I, Munro J, et al. (2010). LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells. J Cell Biol 191: 169-185.
115. Semba S, Iwaya K, Matsubayashi J, Serizawa H, Kataba H, Hirano T, et al. (2006). Coexpression of actin-related protein 2 and Wiskott-Aldrich syndrome family verproline-homologous protein 2 in adenocarcinoma of the lung. Clin Cancer Res 12: 2449-2454.
116. Shum MS, Pasquier E, Po'uha ST, O'Neill GM, Chaponnier C, Gunning PW, et al. (2011). γ-Actin regulates cell migration and modulates the ROCK signaling pathway. FASEB J 25: 4423-4433.
117. Sihag RK, Inagaki M, Yamaguchi T, Shea TB, Pant HC, (2007). Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments. Exp Cell Res 313: 2098-2109.
118. Sinha P, Hutter G, Kottgen E, Dietel M, Schadendorf D, Lage H, (1999). Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-sigma (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas. Electrophoresis 20: 2952-2960.
119. Small JV, Stradal T, Vignal E, Rottner K, (2002). The lamellipodium: where motility begins. Trends Cell Biol 12: 112-120.
120. Sobel A, Tashjian AH Jr, (1983). Distinct patterns of cytoplasmic protein phosphorylation related to regulation of synthesis and release of prolactin by GH cells. J Biol Chem 258: 10312-10324.
121. Steeg PS, (2006). Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12: 895-904.
122. Stehn JR, Haass NK, Bonello T, Desouza M, Kottyan G, Treutlein H, et al. (2013). A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells. Cancer Res 73: 5169-5182.
123. Takahashi K, (2012). WAVE2 protein complex coupled to membrane and microtubules. J Oncol 2012: 590531.
124. Takes RP, Baatenburg de Jong RJ, Schuuring E, Hermans J, Vis AA, Litvinov SV, et al. (1997). Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 123: 412-419.
125. Thiery JP, Acloque H, Huang RY, Nieto MA, (2009). Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
126. Toyoda A, Kawana H, Azuhata K, Yu J, Omata A, Kishi H, et al. (2009). Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression. Int J Oncol 34: 53-60.
127. Trovik J, Wik E, Stefansson IM, Marcickiewicz J, Tingulstad S, Staff AC, et al. (2011). Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer. Clin Cancer Res 17: 3368-3377.
128. Tsuruta D, Jones JC, (2003). The vimentin cytoskeleton regulates focal contact size and adhesion of endothelial cells subjected to shear stress. J Cell Sci 116 (Pt 24): 4977-4984.
129. Turhani D, Krapfenbauer K, Thurnher D, Langen H, Fountoulakis M, (2006). Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis. Electrophoresis 27: 1417-1423.
130. Tybulewicz VL, Henderson RB, (2009). Rho family GTPases and their regulators in lymphocytes. Nat Rev Immunol 9: 630-644.
131. Vaughan S, Dawe HR, (2011). Common themes in centriole and centrosome movements. Trends Cell Biol 21: 57-66.
132. Vega FM, Ridley AJ, (2008). Rho GTPases in cancer cell biology. FEBS Lett 582: 2093-2101.
133. Verhey KJ, Gaertig J, (2007). The tubulin code. Cell Cycle 6: 2152-2160.
134. Verrills NM, Liem NL, Liaw TY, Hood BD, Lock RB, Kavallaris M, (2006a). Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia-an in vivo study. Proteomics 6: 1681-1694.
135. Verrills NM, Po'uha ST, Liu ML, Liaw TY, Larsen MR, Ivery MT, et al. (2006b). Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia. J Natl Cancer Inst 98: 1363-1374.
136. de Vicente JC, Rosado P, Lequerica-Fernandez P, Allonca E, Villallain L, Hernandez-Vallejo G, (2013). Focal adhesion kinase overexpression: correlation with lymph node metastasis and shorter survival in oral squamous cell carcinoma. Head Neck 35: 826-830.
137. Wang W, Goswami S, Lapidus K, Wells AL, Wyckoff JB, Sahai E, et al. (2004). Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 64: 8585-8594.
138. Wang W, Mouneimne G, Sidani M, Wyckoff J, Chen X, Makris A, et al. (2006). The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors. J Cell Biol 173: 395-404.
139. Wang W, Eddy R, Condeelis J, (2007). The cofilin pathway in breast cancer invasion and metastasis. Nat Rev Cancer 7: 429-440.
140. Wang WS, Zhong HJ, Xiao DW, Huang X, Liao LD, Xie ZF, et al. (2010a). The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features. Dis Esophagus 23: 512-521.
141. Wang X, Cao W, Mo M, Wang W, Wu H, Wang J, (2010b). VEGF and cortactin expression are independent predictors of tumor recurrence following curative resection of gastric cancer. J Surg Oncol 102: 325-330.
142. Wei SH, Lin F, Wang X, Gao P, Zhang HZ, (2008). Prognostic significance of stathmin expression in correlation with metastasis and clinicopathological characteristics in human ovarian carcinoma. Acta Histochem 110: 59-65.
143. Wittmann T, Waterman-Storer CM, (2001). Cell motility: can Rho GTPases and microtubules point the way? J Cell Sci 114 (Pt 21): 3795-3803.
144. Wittmann T, Bokoch GM, Waterman-Storer CM, (2004). Regulation of microtubule destabilizing activity of Op18/stathmin downstream of Rac1. J Biol Chem 279: 6196-6203.
145. Wyckoff JB, Pinner SE, Gschmeissner S, Condeelis JS, Sahai E, (2006). ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr Biol 16: 1515-1523.
146. Xu XZ, Garcia MV, Li TY, Khor LY, Gajapathy RS, Spittle C, et al. (2010). Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression. Mod Pathol 23: 187-196.
147. Yamada S, Yanamoto S, Kawasaki G, Mizuno A, Nemoto TK, (2010). Overexpression of cortactin increases invasion potential in oral squamous cell carcinoma. Pathol Oncol Res 16: 523-531.
148. Yamaguchi H, Condeelis J, (2007). Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta 1773: 642-652.
149. Yanagawa R, Furukawa Y, Tsunoda T, Kitahara O, Kameyama M, Murata K, et al. (2001). Genome-wide screening of genes showing altered expression in liver metastases of human colorectal cancers by cDNA microarray. Neoplasia 3: 395-401.
150. Yee HF Jr, Melton AC, Tran BN, (2001). RhoA/rho-associated kinase mediates fibroblast contractile force generation. Biochem Biophys Res Commun 280: 1340-1345.
151. Yoon SO, Shin S, Mercurio AM, (2005). Hypoxia stimulates carcinoma invasion by stabilizing microtubules and promoting the Rab11 trafficking of the alpha6beta4 integrin. Cancer Res 65: 2761-2769.
152. Yoshida T, Ozawa Y, Kimura T, Sato Y, Kuznetsov G, Xu S, et al. (2014). Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states. Br J Cancer 101: 1497-1505.
153. Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G, (2004). Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med 10: 175-181.
154. Zhang T, Zaal KJ, Sheridan J, Mehta A, Gundersen GG, Ralston E, (2009). Microtubule plus-end binding protein EB1 is necessary for muscle cell differentiation, elongation and fusion. J Cell Sci 122 (Pt 9): 1401-1409.
155. Zhu XL, Liang L, Ding YQ, (2008). Overexpression of FMNL2 is closely related to metastasis of colorectal cancer. Int J Colorectal Dis 23: 1041-1047.